OUR APPROACH

ARTIFICIAL INTELLIGENCE

AI has revolutionised the way drugs are discovered.We use AI to discover new indications for existing drugs, derisking clinical development and reducing the cost and time needed to bring an effective drug to market.

DRUG REPURPOSING

Our drug repurposing activities focus on orphan diseases with high unmet medical needs, high potential market values and high regulatory and IP protection. Drug repurposing significantly lowers drug development costs, decreases development time and represents a growing market, currently estimated at USD 317 billion.

ORPHAN
DISEASES

Most orphan diseases are life threatening, therefore there is an urgent need to find new treatments. The global orphan disease market has been growing strongly at 10%+ CAGR and is expected to reach USD 242 billion in 2024

SOMAIPRO, OUR AI ENGINE, IS A DIFFERENTIATED AND CLINICALLY VALIDATED PLATFORM

Based on genetic algorithms
It offers proven predictivity, reducing development time, risks and costs

Identification of drugs for an indication

Chemical structure
List of drugs for the indication

Identification of new indications for a drug

Drug
List of new indications for the drug
Learn how we can apply it for your company
You can find articles about SOMAIPRO published in Yahoo Finance, PRNewswire, Markets Insider, One News San Francisco.